The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Hepatitis E Diagnostic Tests Market Research Report 2025
Synopsis
Hepatitis E is a virus that affects your liver.
The global Hepatitis E Diagnostic Tests market was valued at US$ 42 million in 2023 and is anticipated to reach US$ 49 million by 2030, witnessing a CAGR of 2.2% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Hepatitis E Diagnostic Tests, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hepatitis E Diagnostic Tests.
Report Scope
The Hepatitis E Diagnostic Tests market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hepatitis E Diagnostic Tests market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hepatitis E Diagnostic Tests companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Chemeurope
Wantai Biological
Biokit
Dia.Pro Diagnostic Bioprobes
Roche
Fast-track diagnostics
Fortress Diagnostics
Mikrogen
MP Biomedicals
Segment by Type
ELISA HEV IgM Test kits
ELISA HEV IgG Test Kits
RT-PCR Test Kits
Segment by Application
Hospitals
Diagnostic Laboratories
Research Centers
Point of Care
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hepatitis E Diagnostic Tests companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Hepatitis E is a virus that affects your liver.
The global Hepatitis E Diagnostic Tests market was valued at US$ 42 million in 2023 and is anticipated to reach US$ 49 million by 2030, witnessing a CAGR of 2.2% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Hepatitis E Diagnostic Tests, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hepatitis E Diagnostic Tests.
Report Scope
The Hepatitis E Diagnostic Tests market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hepatitis E Diagnostic Tests market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hepatitis E Diagnostic Tests companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Chemeurope
Wantai Biological
Biokit
Dia.Pro Diagnostic Bioprobes
Roche
Fast-track diagnostics
Fortress Diagnostics
Mikrogen
MP Biomedicals
Segment by Type
ELISA HEV IgM Test kits
ELISA HEV IgG Test Kits
RT-PCR Test Kits
Segment by Application
Hospitals
Diagnostic Laboratories
Research Centers
Point of Care
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hepatitis E Diagnostic Tests companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hepatitis E Diagnostic Tests Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 ELISA HEV IgM Test kits
1.2.3 ELISA HEV IgG Test Kits
1.2.4 RT-PCR Test Kits
1.3 Market by Application
1.3.1 Global Hepatitis E Diagnostic Tests Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Diagnostic Laboratories
1.3.4 Research Centers
1.3.5 Point of Care
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hepatitis E Diagnostic Tests Market Perspective (2019-2030)
2.2 Hepatitis E Diagnostic Tests Growth Trends by Region
2.2.1 Global Hepatitis E Diagnostic Tests Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Hepatitis E Diagnostic Tests Historic Market Size by Region (2019-2024)
2.2.3 Hepatitis E Diagnostic Tests Forecasted Market Size by Region (2025-2030)
2.3 Hepatitis E Diagnostic Tests Market Dynamics
2.3.1 Hepatitis E Diagnostic Tests Industry Trends
2.3.2 Hepatitis E Diagnostic Tests Market Drivers
2.3.3 Hepatitis E Diagnostic Tests Market Challenges
2.3.4 Hepatitis E Diagnostic Tests Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hepatitis E Diagnostic Tests Players by Revenue
3.1.1 Global Top Hepatitis E Diagnostic Tests Players by Revenue (2019-2024)
3.1.2 Global Hepatitis E Diagnostic Tests Revenue Market Share by Players (2019-2024)
3.2 Global Hepatitis E Diagnostic Tests Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hepatitis E Diagnostic Tests Revenue
3.4 Global Hepatitis E Diagnostic Tests Market Concentration Ratio
3.4.1 Global Hepatitis E Diagnostic Tests Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hepatitis E Diagnostic Tests Revenue in 2023
3.5 Hepatitis E Diagnostic Tests Key Players Head office and Area Served
3.6 Key Players Hepatitis E Diagnostic Tests Product Solution and Service
3.7 Date of Enter into Hepatitis E Diagnostic Tests Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hepatitis E Diagnostic Tests Breakdown Data by Type
4.1 Global Hepatitis E Diagnostic Tests Historic Market Size by Type (2019-2024)
4.2 Global Hepatitis E Diagnostic Tests Forecasted Market Size by Type (2025-2030)
5 Hepatitis E Diagnostic Tests Breakdown Data by Application
5.1 Global Hepatitis E Diagnostic Tests Historic Market Size by Application (2019-2024)
5.2 Global Hepatitis E Diagnostic Tests Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Hepatitis E Diagnostic Tests Market Size (2019-2030)
6.2 North America Hepatitis E Diagnostic Tests Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Hepatitis E Diagnostic Tests Market Size by Country (2019-2024)
6.4 North America Hepatitis E Diagnostic Tests Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hepatitis E Diagnostic Tests Market Size (2019-2030)
7.2 Europe Hepatitis E Diagnostic Tests Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Hepatitis E Diagnostic Tests Market Size by Country (2019-2024)
7.4 Europe Hepatitis E Diagnostic Tests Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hepatitis E Diagnostic Tests Market Size (2019-2030)
8.2 Asia-Pacific Hepatitis E Diagnostic Tests Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Hepatitis E Diagnostic Tests Market Size by Region (2019-2024)
8.4 Asia-Pacific Hepatitis E Diagnostic Tests Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Hepatitis E Diagnostic Tests Market Size (2019-2030)
9.2 Latin America Hepatitis E Diagnostic Tests Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Hepatitis E Diagnostic Tests Market Size by Country (2019-2024)
9.4 Latin America Hepatitis E Diagnostic Tests Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hepatitis E Diagnostic Tests Market Size (2019-2030)
10.2 Middle East & Africa Hepatitis E Diagnostic Tests Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Hepatitis E Diagnostic Tests Market Size by Country (2019-2024)
10.4 Middle East & Africa Hepatitis E Diagnostic Tests Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Chemeurope
11.1.1 Chemeurope Company Detail
11.1.2 Chemeurope Business Overview
11.1.3 Chemeurope Hepatitis E Diagnostic Tests Introduction
11.1.4 Chemeurope Revenue in Hepatitis E Diagnostic Tests Business (2019-2024)
11.1.5 Chemeurope Recent Development
11.2 Wantai Biological
11.2.1 Wantai Biological Company Detail
11.2.2 Wantai Biological Business Overview
11.2.3 Wantai Biological Hepatitis E Diagnostic Tests Introduction
11.2.4 Wantai Biological Revenue in Hepatitis E Diagnostic Tests Business (2019-2024)
11.2.5 Wantai Biological Recent Development
11.3 Biokit
11.3.1 Biokit Company Detail
11.3.2 Biokit Business Overview
11.3.3 Biokit Hepatitis E Diagnostic Tests Introduction
11.3.4 Biokit Revenue in Hepatitis E Diagnostic Tests Business (2019-2024)
11.3.5 Biokit Recent Development
11.4 Dia.Pro Diagnostic Bioprobes
11.4.1 Dia.Pro Diagnostic Bioprobes Company Detail
11.4.2 Dia.Pro Diagnostic Bioprobes Business Overview
11.4.3 Dia.Pro Diagnostic Bioprobes Hepatitis E Diagnostic Tests Introduction
11.4.4 Dia.Pro Diagnostic Bioprobes Revenue in Hepatitis E Diagnostic Tests Business (2019-2024)
11.4.5 Dia.Pro Diagnostic Bioprobes Recent Development
11.5 Roche
11.5.1 Roche Company Detail
11.5.2 Roche Business Overview
11.5.3 Roche Hepatitis E Diagnostic Tests Introduction
11.5.4 Roche Revenue in Hepatitis E Diagnostic Tests Business (2019-2024)
11.5.5 Roche Recent Development
11.6 Fast-track diagnostics
11.6.1 Fast-track diagnostics Company Detail
11.6.2 Fast-track diagnostics Business Overview
11.6.3 Fast-track diagnostics Hepatitis E Diagnostic Tests Introduction
11.6.4 Fast-track diagnostics Revenue in Hepatitis E Diagnostic Tests Business (2019-2024)
11.6.5 Fast-track diagnostics Recent Development
11.7 Fortress Diagnostics
11.7.1 Fortress Diagnostics Company Detail
11.7.2 Fortress Diagnostics Business Overview
11.7.3 Fortress Diagnostics Hepatitis E Diagnostic Tests Introduction
11.7.4 Fortress Diagnostics Revenue in Hepatitis E Diagnostic Tests Business (2019-2024)
11.7.5 Fortress Diagnostics Recent Development
11.8 Mikrogen
11.8.1 Mikrogen Company Detail
11.8.2 Mikrogen Business Overview
11.8.3 Mikrogen Hepatitis E Diagnostic Tests Introduction
11.8.4 Mikrogen Revenue in Hepatitis E Diagnostic Tests Business (2019-2024)
11.8.5 Mikrogen Recent Development
11.9 MP Biomedicals
11.9.1 MP Biomedicals Company Detail
11.9.2 MP Biomedicals Business Overview
11.9.3 MP Biomedicals Hepatitis E Diagnostic Tests Introduction
11.9.4 MP Biomedicals Revenue in Hepatitis E Diagnostic Tests Business (2019-2024)
11.9.5 MP Biomedicals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
